Raising Awareness

We are the voice of the kidney cancer community in Washington, D.C., and the United States. Without our input, the people who make decisions about legislation and research funding won’t understand the need for money to be dedicated specifically to kidney cancer research. Your stories, your experiences, your voice … it makes a powerful impression.

Speak up with us!

Kidney cancer research is underfunded

40 Lives per day

This year,  more than 76,000 Americans will be diagnosed with kidney cancer and almost 14,000 kidney cancer patients will lose their lives. The need for research and additional treatment options is urgent. 

A Poor Prognosis

Despite amazing strides in kidney cancer treatment, the prognosis for those with stage IV disease remains poor. The five-year survival rate is just under 10%.

More work needs doing, and we advocate to fund that work.

FUNDING HAPPENS IN D.C.

Every year, lobbyists flood Washington, D.C., to ensure that their interests get prioritized when Congress appropriates funding. In this video, KidneyCAN President Bryan Lewis explains how you have to speak up and get a seat at that table — otherwise, “you’re on the menu.”

A TELLING COMPARISON

Melanoma and kidney cancer have long been considered sister diseases. Both have dire prognoses and a very poor response to traditional chemotherapy and radiation therapy. Both are among the most responsive of all cancers to immunotherapy.

Statistics show 40% more patients die from kidney cancer each year than melanoma. However, in recent years, melanoma research has received in both private funding and federal grants many times the funding for kidney cancer research.

Ready to Fight?

There are so many ways you can help. We need your voice! If every person impacted by kidney cancer did a little to speak up for the community, we would be impossible to ignore.

The Need for Advocacy & Involvement

DISTRICT DAYS 2021

BE AN ADVOCATE

WAYS TO GIVE

Join Our Grassroots Army

We know that awareness of kidney cancer and its impact on many lives leads to a sense of urgency, a desire for solutions. Awareness leads to advocacy, and advocacy — joining to speak as one voice — leads to funding and research. That’s how we get to cures.

For this installment of #KidneyCANDID, Dr. Sumanta Pal of City of Hope shares two things patients can do as they prepare for their #kidneycancer appointments.
▶️ Questions & Support: What to Bring to Your Kidney Cancer Oncology Appointment
Watch here: https://youtu.be/eSHbG7OeYHg
Have a topic you'd like us to cover in another episode of #KidneyCANDID? Comment below or email us at info@kidneycan.org!

For this installment of #KidneyCANDID, Dr. Sumanta Pal of City of Hope shares two things patients can do as they prepare for their #kidneycancer appointments.

▶️ Questions & Support: What to Bring to Your Kidney Cancer Oncology Appointment

Watch here: https://youtu.be/eSHbG7OeYHg

Have a topic you'd like us to cover in another episode of #KidneyCANDID? Comment below or email us at [email protected]!
...

13 1
It's not too late to join us for the next Town Hall event in our series! Learn about shared decision-making and your immunotherapy choices from leading oncologists. 
Register now: https://bit.ly/ImmunotherapyTownHall
#kidneycan #immunotherapy #townhall #livingwithcancer #cancerlife #kidneycancer #patienteducation

It's not too late to join us for the next Town Hall event in our series! Learn about shared decision-making and your immunotherapy choices from leading oncologists.

Register now: https://bit.ly/ImmunotherapyTownHall

#kidneycan #immunotherapy #townhall #livingwithcancer #cancerlife #kidneycancer #patienteducation
...

7 0
It's not too late to register for our next Town Hall event! Learn about immunotherapy choices for #kidneycancer treatment from leading oncologists. We'll have Dr. Naomi Haas from Penn Medicine, Dr. Hans Hammers from UTSW, and Dr. Monty Pal from City of Hope. 
📅 Tues, April 26
🕔 5:00 PM EDT
💻 Free Webinar via Zoom
Register now! https://bit.ly/ImmunotherapyTownHall
#kidneycan #livingwithcancer #cancerlife #patienteducation #empoweredpatient #shareddecisionmaking

It's not too late to register for our next Town Hall event! Learn about immunotherapy choices for #kidneycancer treatment from leading oncologists. We'll have Dr. Naomi Haas from Penn Medicine, Dr. Hans Hammers from UTSW, and Dr. Monty Pal from City of Hope.

📅 Tues, April 26
🕔 5:00 PM EDT
💻 Free Webinar via Zoom

Register now! https://bit.ly/ImmunotherapyTownHall

#kidneycan #livingwithcancer #cancerlife #patienteducation #empoweredpatient #shareddecisionmaking
...

7 0
Reminder! Our next patient education town hall will explore immunotherapy options for #kidneycancer patients. 
📅  April 26th
🕔 5:00 pm ET
💻 via Zoom webinar
Register here: https://bit.ly/ImmunotherapyTownHall
Featuring Drs. Naomi Haas of UPenn, Hans Hammers of UTSW, and Monty Pal of City of Hope. Join us to hear this panel of leading expert oncologists discuss how they share the immunotherapy decision-making process with their patients.

Reminder! Our next patient education town hall will explore immunotherapy options for #kidneycancer patients.

📅 April 26th
🕔 5:00 pm ET
💻 via Zoom webinar

Register here: https://bit.ly/ImmunotherapyTownHall

Featuring Drs. Naomi Haas of UPenn, Hans Hammers of UTSW, and Monty Pal of City of Hope. Join us to hear this panel of leading expert oncologists discuss how they share the immunotherapy decision-making process with their patients.
...

7 0
Researchers! KidneyCAN is accepting abstracts for the 2022 Kidney Cancer Research Summit on October 6-7 in Philadelphia, PA. 
Don't miss the opportunity to be part of this incredible meeting for #kidneycancer specialists. 
Abstract submission guidelines and full details here: http://bit.ly/KCRS22Abstracts
#kidneycancerresearch #cancerresearch #kcsm

Researchers! KidneyCAN is accepting abstracts for the 2022 Kidney Cancer Research Summit on October 6-7 in Philadelphia, PA.

Don't miss the opportunity to be part of this incredible meeting for #kidneycancer specialists.

Abstract submission guidelines and full details here: http://bit.ly/KCRS22Abstracts

#kidneycancerresearch #cancerresearch #kcsm
...

6 0
Another educational opportunity for #KidneyCancer patients! 
Learn from some of the nation's top doctors at Yale Cancer Center. Tomorrow night (Thursday) at 7:00 PM ET. 
Register: https://zoom.us/webinar/register/WN_1uI0atogTR2VKcFC_W78Fg

Another educational opportunity for #KidneyCancer patients!
Learn from some of the nation's top doctors at Yale Cancer Center. Tomorrow night (Thursday) at 7:00 PM ET.

Register: https://zoom.us/webinar/register/WN_1uI0atogTR2VKcFC_W78Fg
...

8 0
Hear the latest in kidney cancer care, emerging therapies and general wellness from Dr. Thomas Hutson DO, Pharm.D., FACP of Texas Oncology and a panel of experts at @curetoday's Educated Patient® Kidney Cancer Summit on Saturday, April 9th . 
Connect with the kidney cancer community and empower your own journey! 
Learn more and reserve your virtual seat: 
http://ow.ly/weVJ50Ivtjy 
#educatedpatient #kidneycancer

Hear the latest in kidney cancer care, emerging therapies and general wellness from Dr. Thomas Hutson DO, Pharm.D., FACP of Texas Oncology and a panel of experts at @curetoday's Educated Patient® Kidney Cancer Summit on Saturday, April 9th .

Connect with the kidney cancer community and empower your own journey!

Learn more and reserve your virtual seat:
http://ow.ly/weVJ50Ivtjy

#educatedpatient #kidneycancer
...

11 0
We continue to honor the caregivers in our community during #KidneyCancerAwareness month. Tracy shares her insightful perspective along with the decisions she and her wife Julie had to make when facing a diagnosis.
Read more:
https://kidneycan.org/tracys-story-a-caregivers-perspective/
#kidneycancer #caregiving #cancerlife #livingwithcancer #caregiving #KCAM

We continue to honor the caregivers in our community during #KidneyCancerAwareness month. Tracy shares her insightful perspective along with the decisions she and her wife Julie had to make when facing a diagnosis.

Read more:
https://kidneycan.org/tracys-story-a-caregivers-perspective/

#kidneycancer #caregiving #cancerlife #livingwithcancer #caregiving #KCAM
...

9 0
Ralph Knapp, your community loves and remembers you. 
Thank you all for your messages of support. 
🧡💚✨

Ralph Knapp, your community loves and remembers you.

Thank you all for your messages of support.

🧡💚✨
...

34 1

WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORS →

DONATE →

CONTACT →

Latest News

Remembering Ralph: Time Well Spent

Remembering Ralph: Time Well Spent

Ralph Knapp was diagnosed in 2014 with stage IV kidney cancer and used the opportunity to increase research funding and bring hope to patients everywhere. With heavy hearts and profound sadness, we announce the passing of Ralph Knapp, a founder of KidneyCAN and leader of our mission to accelerate...

SPRING ADVOCACY DAYS 2022 →

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

DONATE NOW →

CONTACT →

Latest News

Let’s Get Loud: Spring 2022 Advocacy Days

Let’s Get Loud: Spring 2022 Advocacy Days

On March 7-8, KidneyCAN gathered advocates from all over the United States to ask Congress for robust funding for kidney cancer research through the NIH and CDMRP (Congressionally Directed Medical Research Programs). Read on to hear about our goals for this event and how you can help fund...

Patient Resource Center

UNDERSTANDING YOUR KIDNEY CANCER DIAGNOSIS

BUILDING A CARE TEAM

TREATMENT & TRIAL OPTIONS

LIVING WELL WITH KIDNEY CANCER

KCRS: KIDNEY CANCER RESEARCH SUMMIT →

RESEARCH OPPORTUNITIES →

NEWS →

Latest News

IKCC Report: Retention in Clinical Trials

IKCC Report: Retention in Clinical Trials

The International Kidney Cancer Coalition launched a pilot program to understand the barriers and other considerations that drive the decision to leave a clinical trial and uncover ways to better support patients currently in or considering joining clinical trials. Clinical trials are the key to...

SUPPORT OUR WORK →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News

Remembering Ralph: Time Well Spent

Remembering Ralph: Time Well Spent

Ralph Knapp was diagnosed in 2014 with stage IV kidney cancer and used the opportunity to increase research funding and bring hope to patients everywhere. With heavy hearts and profound sadness, we announce the passing of Ralph Knapp, a founder of KidneyCAN and leader of our mission to accelerate...